Atlas Venture Advisors, Inc. F Star Therapeutics, Inc. Transaction History

Atlas Venture Advisors, Inc.

  • $484 Million
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 01, 2021
BUY
$1.03 - $10.39 $592,245 - $5.97 Million
574,996 New
574,996 $5.68 Million

Others Institutions Holding FSTX

# of Institutions
3
Shares Held
44.7K
Call Options Held
0
Put Options Held
0
View Full List

About F-star Therapeutics, Inc.

FSTX Quotes by TradingView
  • Ticker FSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,584,700
  • Description
  • F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck c...
More about FSTX
Track This Portfolio

Track Atlas Venture Advisors, Inc. Portfolio

Follow Atlas Venture Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Venture Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Atlas Venture Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email